Cubist Systematic Strategies, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q2 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$442,000
-62.1%
2,039
-79.8%
0.01%
-62.5%
Q4 2020$1,166,000
+677.3%
10,100
+557.1%
0.02%
+700.0%
Q3 2020$150,000
-84.6%
1,537
-80.6%
0.00%
-88.2%
Q2 2020$971,000
+239.5%
7,911
+142.2%
0.02%
+112.5%
Q1 2020$286,000
-74.4%
3,266
-69.5%
0.01%
-60.0%
Q4 2019$1,118,000
-24.9%
10,697
-17.4%
0.02%
-33.3%
Q3 2019$1,489,000
+276.0%
12,944
+463.0%
0.03%
+328.6%
Q2 2019$396,000
+31.6%
2,299
+28.7%
0.01%
-30.0%
Q1 2019$301,000
-58.7%
1,786
-76.1%
0.01%
-70.6%
Q4 2018$728,000
+89.6%
7,479
+236.1%
0.03%
+61.9%
Q3 2018$384,000
+291.8%
2,225
+217.9%
0.02%
+320.0%
Q2 2018$98,000
-83.6%
700
-86.8%
0.01%
-85.7%
Q1 2018$597,000
+65.8%
5,300
+94.2%
0.04%
+84.2%
Q4 2017$360,000
-21.4%
2,729
-39.5%
0.02%
-26.9%
Q3 2017$458,000
+1426.7%
4,511
+1403.7%
0.03%
+1200.0%
Q2 2017$30,000
-58.9%
300
-50.0%
0.00%
-60.0%
Q1 2017$73,000
-5.2%
600
-12.7%
0.01%
-16.7%
Q4 2016$77,000
-96.0%
687
-95.3%
0.01%
-95.2%
Q3 2016$1,940,000
+540.3%
14,616
+248.2%
0.12%
+635.3%
Q1 2016$303,000
+320.8%
4,197
+302.4%
0.02%
+325.0%
Q4 2015$72,000
-77.2%
1,043
-59.4%
0.00%
-73.3%
Q2 2015$316,000
-14.4%
2,569
-52.9%
0.02%
-25.0%
Q4 2014$369,000
-25.6%
5,458
+18.2%
0.02%
-33.3%
Q2 2014$496,0004,6190.03%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2014
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders